SAB Biotherapeutics, Inc. - COM NEW (SABS)

Historical Portfolio Holders from Q4 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
3.14M
Holdings value Q3 2024
$8.48M
Value change Q3 2024
+$68.5K
Grand Portfolio weight change Q3 2024
+0%
Number of holders
24
Number of buys Q3 2024
6
Number of sells Q3 2024
-5
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 3.14M $8.48M +$68.5K $2.70 24
2024 Q2 3.13M $9.69M -$924K $3.10 21
2024 Q1 3.34M $15.2M -$15.6M $4.54 23
2023 Q4 8.79M $6.06M +$6.06M $0.69 3